|
David Frisbie
His current joint disease research is in two basic fields: 1) the evaluation of intra-articular therapeutics and their effects on joint disease (well known therapeutics he has evaluated include Legend, Adequan, Vetalog and Depo-Medrol); 2) new methods of cartilage repair. These methods include cutting edge technology aimed at arthroscopic repair of cartilage in the athletic horse. Dr. Frisbie is also exploring methods to augment fracture healing in both noninfected and infected cases using gene transfer. Research Interests: Gene therapy, intra-articular therapeutics,
new methods of cartilage repair
|
![]() |
Mailing Address Department of Clinical Sciences |